Top stories
Addiction
Alcohol
Allergies
Alternative medicine
Alzheimers
Anxiety
Arthritis
Asthma
Bird flu
Cancer
Cancer - Breast
Cholesterol
Cosmetic surgery
Crohn^s Disease
Dental
Depression
Diabetes
Diet
Eyesight
Fitness
Gastroenterology
Health - Kids
Health - Men
Health - Senior
Health - Women
Hearing
Heart
Hepatitis
High Blood Pressure
HIV/AIDS
Infectious Diseases
Lungs
Mental Health
Migraine
Neurology
Nursing
Osteoporosis
Parenting
Physicians
Psychiatry
Radiology
Sexual Health
Skin
Sleep
Smoking
Tobacco
Top Stories
Vitamins
|
Health - Fitness latest news
|
|
Create news alerts
Too Much Or Too Little Weight Gain Poses Risks To Pregnant Mothers, BabiesWomen who gain more or less than recommended amounts of weight during pregnancy are likely to increase the risk of problems for both themselves and their child, according to a new report by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.The report, which was supported by the U.S. Medicalnewstoday.com Friday, May 09, 2008
Data Show Flector(R) Patch Yields Significant Pain Reduction For Acute Strains, Sprains And ContusionsAlpharma Inc. (NYSE:ALO), a leading global specialty pharmaceutical company, announced that two studies to be presented this week at the American Pain Society annual meeting demonstrate the efficacy, tolerability and positive pharmacokinetic profile of Alpharma Pharmaceuticals' FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%, the first and only prescription anti-inflammatory pain relief patch in the United States. Medicalnewstoday.com Friday, May 09, 2008
Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R)Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, announced completion of enrollment in NB-303 and NB-304, the final two Phase III clinical trials for Contrave®, its lead obesity product candidate. Today's announcement marks the completion of patient enrollment for the full Contrave Phase III program, keeping Contrave on track for an NDA submission to the FDA in late 2009. Medicalnewstoday.com Friday, May 09, 2008
The Myths about Strength TrainingWhich exercises should you do to reduce fat over the abs or thighs? And should you lift lighter weights if you're trying to tone your body? These are... About Friday, May 09, 2008
Training Student Leaders Cuts Peers' Smoking Rates (HealthDay)HealthDay - FRIDAY, May 9 (HealthDay News) -- Training influential students
to spread anti- smoking messages in their everyday conversations with peers
helps reduce smoking rates, according to a U.K. study. yahoo.com Friday, May 09, 2008
Two Thirds Of People With Asthma Do Not Lead A Full Life Because Of Their ConditionTwo in three people with asthma feel that their condition is in some way preventing them from achieving what they want from life and one third of patients are living in fear of having an attack, according to a new survey released to mark World Asthma Day. The survey also found that a third of people with asthma worry about the impact asthma will have on their future health. Respondents also indicated that asthma impacts every day life. Medicalnewstoday.com Friday, May 09, 2008
Archived "Health - Fitness" news stories.
Available news archives.
|
June 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
|
1
|
2
|
| 3
|
4
|
5
|
6
|
7
|
8
|
9
|
| 10
|
11
|
12
|
13
|
14
|
15
|
16
|
| 17
|
18
|
19
|
20
|
21
|
22
|
23
|
| 24
|
25
|
26
|
27
|
28
|
29
|
30
|
|
|
|
|
|
|
|
|
|
|
July 2007
|
| S |
M |
T |
W |
T |
F |
S |
| 1
|
2
|
3
|
4
|
5
|
6
|
7
|
| 8
|
9
|
10
|
11
|
12
|
13
|
14
|
| 15
|
16
|
17
|
18
|
19
|
20
|
21
|
| 22
|
23
|
24
|
25
|
26
|
27
|
28
|
| 29
|
30
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
August 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
1
|
2
|
3
|
4
|
| 5
|
6
|
7
|
8
|
9
|
10
|
11
|
| 12
|
13
|
14
|
15
|
16
|
17
|
18
|
| 19
|
20
|
21
|
22
|
23
|
24
|
25
|
| 26
|
27
|
28
|
29
|
30
|
31
|
|
|
|
|
|
|
|
|
|
|
|
September 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
|
|
1
|
| 2
|
3
|
4
|
5
|
6
|
7
|
8
|
| 9
|
10
|
11
|
12
|
13
|
14
|
15
|
| 16
|
17
|
18
|
19
|
20
|
21
|
22
|
| 23
|
24
|
25
|
26
|
27
|
28
|
29
|
| 30
|
|
|
|
|
|
|
|
|
October 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
1
|
2
|
3
|
4
|
5
|
6
|
| 7
|
8
|
9
|
10
|
11
|
12
|
13
|
| 14
|
15
|
16
|
17
|
18
|
19
|
20
|
| 21
|
22
|
23
|
24
|
25
|
26
|
27
|
| 28
|
29
|
30
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
1
|
2
|
3
|
| 4
|
5
|
6
|
7
|
8
|
9
|
10
|
| 11
|
12
|
13
|
14
|
15
|
16
|
17
|
| 18
|
19
|
20
|
21
|
22
|
23
|
24
|
| 25
|
26
|
27
|
28
|
29
|
30
|
|
|
|
|
|
|
|
|
|
|
|
December 2007
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
|
|
1
|
| 2
|
3
|
4
|
5
|
6
|
7
|
8
|
| 9
|
10
|
11
|
12
|
13
|
14
|
15
|
| 16
|
17
|
18
|
19
|
20
|
21
|
22
|
| 23
|
24
|
25
|
26
|
27
|
28
|
29
|
| 30
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
May 2008
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
1
|
2
|
3
|
| 4
|
5
|
6
|
7
|
8
|
9
|
10
|
| 11
|
12
|
13
|
14
|
15
|
16
|
17
|
| 18
|
19
|
20
|
21
|
22
|
23
|
24
|
| 25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
|
|
|
|
|
|
|
|
|